# A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017)

> **NCT05511558** · PHASE1 · COMPLETED · sponsor: **LeonaBio** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** [14C]-Fosgonimeton

## Key facts

- **NCT ID:** NCT05511558
- **Lead sponsor:** LeonaBio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-13
- **Primary completion:** 2022-10-18
- **Final completion:** 2022-10-26
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2022-12-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05511558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05511558, "A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05511558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*